Emerging methods in therapeutics using multifunctional nanoparticles
dc.contributor.author | Habibi, Nahal | |
dc.contributor.author | Quevedo, Daniel F. | |
dc.contributor.author | Gregory, Jason V. | |
dc.contributor.author | Lahann, Joerg | |
dc.date.accessioned | 2020-07-02T20:33:59Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2020-07-02T20:33:59Z | |
dc.date.issued | 2020-07 | |
dc.identifier.citation | Habibi, Nahal; Quevedo, Daniel F.; Gregory, Jason V.; Lahann, Joerg (2020). "Emerging methods in therapeutics using multifunctional nanoparticles." Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 12(4): n/a-n/a. | |
dc.identifier.issn | 1939-5116 | |
dc.identifier.issn | 1939-0041 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/155963 | |
dc.description.abstract | Clinical translation of nanoparticle‐based drug delivery systems is hindered by an array of challenges including poor circulation time and limited targeting. Novel approaches including designing multifunctional particles, cell‐mediated delivery systems, and fabrications of protein‐based nanoparticles have gained attention to provide new perspectives to current drug delivery obstacles in the interdisciplinary field of nanomedicine. Collectively, these nanoparticle devices are currently being investigated for applications spanning from drug delivery and cancer therapy to medical imaging and immunotherapy. Here, we review the current state of the field, highlight opportunities, identify challenges, and present the future directions of the next generation of multifunctional nanoparticle drug delivery platforms.This article is categorized under:Biology‐Inspired Nanomaterials > Protein and Virus‐Based StructuresNanotechnology Approaches to Biology > Nanoscale Systems in BiologyNovel approaches in designing nanoparticles to overcome challenges faced by traditional nanoparticle‐based drug delivery systems. | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.subject.other | drug delivery | |
dc.subject.other | multifunctional nanoparticles | |
dc.subject.other | nanomedicine | |
dc.subject.other | protein nanoparticles | |
dc.subject.other | cellular hitchhiking | |
dc.subject.other | clinical trials | |
dc.subject.other | cancer therapy | |
dc.subject.other | blood–brain barrier | |
dc.title | Emerging methods in therapeutics using multifunctional nanoparticles | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Biomedical Engineering | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/155963/1/wnan1625.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/155963/2/wnan1625_am.pdf | |
dc.identifier.doi | 10.1002/wnan.1625 | |
dc.identifier.source | Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology | |
dc.identifier.citedreference | Si, J., Shao, S., Shen, Y., & Wang, K. ( 2016 ). Macrophages as active nanocarriers for targeted early and adjuvant cancer chemotherapy. Small, 12, 5108 – 5119. https://doi.org/10.1002/smll.201601282 | |
dc.identifier.citedreference | Tian, L., Chen, Q., Yi, X., Wang, G., Chen, J., Ning, P., … Liu, Z. ( 2017 ). Radionuclide I‐131 labeled albumin‐paclitaxel nanoparticles for synergistic combined chemo‐radioisotope therapy of cancer. Theranostics, 7, 614 – 623. https://doi.org/10.7150/thno.17381 | |
dc.identifier.citedreference | Zhao, Y. P., Ye, D. X., Wang, G. C., & Lu, T. M. ( 2002 ). Novel nano‐column and nano‐flower arrays by glancing angle deposition. Nano Letters, 2, 351 – 354. https://doi.org/10.1021/nl0157041 | |
dc.identifier.citedreference | Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., … Nie, G. ( 2014 ). Biomaterials A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials, 35, 2383 – 2390. https://doi.org/10.1016/j.biomaterials.2013.11.083 | |
dc.identifier.citedreference | Tomaiuolo, G. ( 2014 ). Biomechanical properties of red blood cells in health and disease towards microfluidics. Biomicrofluidics, 8, 051501. https://doi.org/10.1063/1.4895755 | |
dc.identifier.citedreference | Tsoras, A. N., & Champion, J. A. ( 2018 ). Cross‐linked peptide nanoclusters for delivery of oncofetal antigen as a cancer vaccine. Bioconjugate Chemistry, 29, 776 – 785. https://doi.org/10.1021/acs.bioconjchem.8b00079 | |
dc.identifier.citedreference | Turley, C. B., Rupp, R. E., Johnson, C., Taylor, D. N., Wolfson, J., Tussey, L., … Shaw, A. ( 2011 ). Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine, 29, 5145 – 5152. https://doi.org/10.1016/J.VACCINE.2011.05.041 | |
dc.identifier.citedreference | Van Dommelen, S. M., Vader, P., Lakhal, S., Kooijmans, S. A. A., Van Solinge, W. W., Wood, M. J. A., & Schiffelers, R. M. ( 2012 ). Microvesicles and exosomes: Opportunities for cell‐derived membrane vesicles in drug delivery. Journal of Controlled Release, 161, 635 – 644. https://doi.org/10.1016/j.jconrel.2011.11.021 | |
dc.identifier.citedreference | Varadharajan, D., Turgut, H., Lahann, J., Yabu, H., & Delaittre, G. ( 2018 ). Surface‐reactive patchy nanoparticles and nanodiscs prepared by tandem nanoprecipitation and internal phase separation. Advanced Functional Materials, 1800846, 1 – 11. https://doi.org/10.1002/adfm.201800846 | |
dc.identifier.citedreference | Ventola, C. L. ( 2017 ). Progress in nanomedicine: Approved and investigational nanodrugs. P & T, 42, 742 – 755. | |
dc.identifier.citedreference | Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. ( 2016 ). Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems. Advanced Drug Delivery Reviews, 106, 88 – 103. https://doi.org/10.1016/j.addr.2016.02.007 | |
dc.identifier.citedreference | Villa, C. H., Cines, D. B., Siegel, D. L., & Muzykantov, V. ( 2017 ). Erythrocytes as carriers for drug delivery in blood transfusion and beyond. Transfusion Medicine Reviews, 31, 26 – 35. https://doi.org/10.1016/j.tmrv.2016.08.004 | |
dc.identifier.citedreference | Villa, C. H., Seghatchian, J., & Muzykantov, V. ( 2016 ). Transfusion and apheresis science drug delivery by erythrocytes: “Primum non nocere”. Transfusion and Apheresis Science, 55, 275 – 280. https://doi.org/10.1016/j.transci.2016.10.017 | |
dc.identifier.citedreference | Von Storp, B., Engel, A., Boeker, A., Ploeger, M., & Langer, K. ( 2012 ). Albumin nanoparticles with predictable size by desolvation procedure. Journal of Microencapsulation, 29, 138 – 146. https://doi.org/10.3109/02652048.2011.635218 | |
dc.identifier.citedreference | Wang, Y., Zhang, Y., & Wang, B. ( 2013 ). Fabrication of core—Shell micro/nanoparticles for programmable dual drug release by emulsion electrospraying. Journal of Nanoparticle Research, 15, 1 – 12. https://doi.org/10.1007/s11051-013-1726-y | |
dc.identifier.citedreference | Wayteck, L., Dewitte, H., De Backer, L., Breckpot, K., Demeester, J., De Smedt, S. C., & Raemdonck, K. ( 2016 ). Hitchhiking nanoparticles: Reversible coupling of lipid‐based nanoparticles to cytotoxic T lymphocytes. Biomaterials, 77, 243 – 254. https://doi.org/10.1016/j.biomaterials.2015.11.016 | |
dc.identifier.citedreference | Weber, C., Coester, C., Kreuter, J., & Langer, K. ( 2000 ). Desolvation process and surface characterisation of protein nanoparticles. International Journal of Pharmaceutics, 194, 91 – 102. https://doi.org/10.1016/S0378-5173(99)00370-1 | |
dc.identifier.citedreference | Wiley, D. T., Webster, P., Gale, A., & Davis, M. E. ( 2013 ). Transcytosis and brain uptake of transferrin‐containing nanoparticles by tuning avidity to transferrin receptor. Proceedings of the National Academy of Sciences, 110, 8662 – 8667. https://doi.org/10.1073/pnas.1307152110 | |
dc.identifier.citedreference | Wu, Z., Li, T., Li, J., Gao, W., Xu, T., Christianson, C., … Wang, J. ( 2014 ). Turning erythrocytes into functional micromotors. ACS Nano, 8, 12041 – 12048. https://doi.org/10.1021/nn506200x | |
dc.identifier.citedreference | Yake, A. M., Snyder, C. E., & Velegol, D. ( 2007 ). Site‐specific functionalization on individual colloids: Size control, stability, and multilayers. Langmuir, 23, 9069 – 9075. https://doi.org/10.1021/la7011292 | |
dc.identifier.citedreference | Yake, A. M., Zahr, A. S., Jerri, H. A., Pishko, M. V., & Velegol, D. ( 2007 ). Localized functionalization of individual colloidal carriers for cell targeting and imaging. Biomacromolecules, 8, 1958 – 1965. https://doi.org/10.1021/bm070071r | |
dc.identifier.citedreference | Yeates, T. O., Liu, Y., & Laniado, J. ( 2016 ). The design of symmetric protein nanomaterials comes of age in theory and practice. Current Opinion in Structural Biology, 39, 134 – 143. https://doi.org/10.1016/j.sbi.2016.07.003 | |
dc.identifier.citedreference | Yuet, K. P., Hwang, D. K., Haghogooie, R., & Doyle, P. S. ( 2010 ). Multifunctional superparamagnetic Janus particles. Langmuir, 26, 4281 – 4287. https://doi.org/10.1021/la903348s | |
dc.identifier.citedreference | Zhang, J., Jin, J., & Zhao, H. ( 2009 ). Surface‐initiated free radical polymerization at the liquid‐liquid interface: A one‐step approach for the synthesis of amphiphilic janus silica particles. Langmuir, 25, 6431 – 6437. https://doi.org/10.1021/la9000279 | |
dc.identifier.citedreference | Zhang, P., Sun, F., Liu, S., & Jiang, S. ( 2016 ). Anti‐PEG antibodies in the clinic: Current issues and beyond PEGylation. Journal of Controlled Release, 284, 183 – 193. https://doi.org/10.1016/j.jconrel.2016.06.040 | |
dc.identifier.citedreference | Zhen, Z., Tang, W., Chen, H., Lin, X., Todd, T., Wang, G., … Xie, J. ( 2013 ). RGD‐modified apoferritin nanoparticles for efficient drug delivery to tumors. ACS Nano, 7, 4830 – 4837. https://doi.org/10.1021/nn305791q | |
dc.identifier.citedreference | Zou, H., Wang, Z., & Feng, M. ( 2015 ). Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery. Journal of Controlled Release, 214, 121 – 133. https://doi.org/10.1016/J.JCONREL.2015.07.014 | |
dc.identifier.citedreference | Agrahari, V., Agrahari, V., & Mitra, A. K. ( 2017 ). Next generation drug delivery: Circulatory cells‐mediated nanotherapeutic approaches. Expert Opinion on Drug Delivery, 14, 285 – 289. https://doi.org/10.1080/17425247.2017.1254614 | |
dc.identifier.citedreference | Alvarez‐Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. ( 2011 ). Letters delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology, 29, 341 – 345. https://doi.org/10.1038/nbt.1807 | |
dc.identifier.citedreference | Amani, S. B., Makkouk, R., & Sun, T. K. C. ( 2011 ). Photothermal treatment of glioma: An in vitro study of macrophage‐mediated delivery of gold nanoshells. Journal of Neuro‐Oncology, 104, 439 – 448. https://doi.org/10.1007/s11060-010-0511-3 | |
dc.identifier.citedreference | Anselmo, A. C., Gilbert, J. B., Kumar, S., Gupta, V., Cohen, R. E., Rubner, M. F., & Mitragotri, S. ( 2015 ). Monocyte‐mediated delivery of polymeric backpacks to in flamed tissues: A generalized strategy to deliver drugs to treat inflammation. Journal of Controlled Release, 199, 29 – 36. https://doi.org/10.1016/j.jconrel.2014.11.027 | |
dc.identifier.citedreference | Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. ( 2013 ). Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS Nano, 7, 11129 – 11137. https://doi.org/10.1021/nn404853z | |
dc.identifier.citedreference | Anselmo, A. C., Kumar, S., Gupta, V., Pearce, A. M., Ragusa, A., Muzykantov, V., & Mitragotri, S. ( 2015 ). Exploiting shape, cellular‐hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches. Biomaterials, 68, 1 – 8. https://doi.org/10.1016/j.biomaterials.2015.07.043 | |
dc.identifier.citedreference | Anselmo, A. C., & Mitragotri, S. ( 2014a ). Cell‐mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles. Journal of Controlled Release, 190, 531 – 541. https://doi.org/10.1016/j.jconrel.2014.03.050 | |
dc.identifier.citedreference | Anselmo, A. C., & Mitragotri, S. ( 2016 ). Nanoparticles in the clinic. Bioengineering & Translational Medicine, 1, 10 – 29. https://doi.org/10.1002/btm2.10003 | |
dc.identifier.citedreference | Arai, R. ( 2018 ). Hierarchical design of artificial proteins and complexes toward synthetic structural biology. Biophysical Reviews, 10, 391 – 410. https://doi.org/10.1007/s12551-017-0376-1 | |
dc.identifier.citedreference | Armstrong, J. P. K., & Stevens, M. M. ( 2018 ). Strategic design of extracellular vesicle drug delivery systems. Advanced Drug Delivery Reviews, 130, 12 – 16. https://doi.org/10.1016/j.addr.2018.06.017 | |
dc.identifier.citedreference | Arnold, F. H. ( 2018 ). Directed evolution: Bringing new chemistry to life. Angewandte Chemie, 57, 4143 – 4148. https://doi.org/10.1002/anie.201708408 | |
dc.identifier.citedreference | Ayer, M., & Klok, H. ( 2017 ). Cell‐mediated delivery of synthetic nano‐ and microparticles. Journal of Controlled Release, 259, 92 – 104. https://doi.org/10.1016/j.jconrel.2017.01.048 | |
dc.identifier.citedreference | Batrakova, E. V., Gendelman, H. E., Kabanov, A. V., Batrakova, E. V., Gendelman, H. E., & Kabanov, A. V. ( 2011 ). Cell‐mediated drug delivery. Expert Opinion on Drug Delivery, 8, 415 – 433. https://doi.org/10.1517/17425247.2011.559457 | |
dc.identifier.citedreference | Batrakova, E. V., & Kim, M. S. ( 2015 ). Using exosomes, naturally‐equipped nanocarriers, for drug delivery. Journal of Controlled Release, 219, 396 – 405. https://doi.org/10.1016/j.jconrel.2015.07.030 | |
dc.identifier.citedreference | Batrakova, E. V., Li, S., Reynolds, A. D., Mosley, R. L., Bronich, T. K., Kabanov, A. V., & Gendelman, H. E. ( 2007 ). A macrophage—Nanozyme delivery system for Parkinson’s disease. Bioconjugate Chemistry, 18, 1498 – 1506. https://doi.org/10.1021/bc700184b | |
dc.identifier.citedreference | Blanco, E., Shen, H., & Ferrari, M. ( 2015 ). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology, 33, 941 – 951. https://doi.org/10.1038/nbt.3330 | |
dc.identifier.citedreference | Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. ( 2016 ). Nanoparticle‐based medicines: A review of FDA‐approved materials and clinical trials to date. Pharmaceutical Research, 33, 2373 – 2387. https://doi.org/10.1007/s11095-016-1958-5 | |
dc.identifier.citedreference | Brenner, J. S., Pan, D. C., Myerson, J. W., Marcos‐Contreras, O. A., Villa, C. H., Patel, P., … Bhamidipati, K. ( 2018 ). Red blood cell‐hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude. Nature Communications, 9, 1 – 14. https://doi.org/10.1038/s41467-018-05079-7 | |
dc.identifier.citedreference | Cao, Y., Wang, B., Wang, Y., & Lou, D. ( 2014 ). Dual drug release from core–shell nanoparticles with distinct release profiles. Journal of Pharmaceutical Sciences, 103, 3205 – 3216. https://doi.org/10.1002/jps.24116 | |
dc.identifier.citedreference | Castro, N., Constantin, D., Davidson, P., & Abécassis, B. ( 2016 ). Solution self‐assembly of plasmonic Janus nanoparticles. Soft Matter, 12, 9666 – 9673. https://doi.org/10.1039/C6SM01632D | |
dc.identifier.citedreference | Cha, C., Oh, J., Kim, K., Qiu, Y., Joh, M., Shin, S. R., … Khademhosseini, A. ( 2014 ). Microfluidics‐assisted fabrication of gelatin‐silica core‐shell microgels for injectable tissue constructs. Biomacromolecules, 15, 283 – 290. https://doi.org/10.1021/bm401533y | |
dc.identifier.citedreference | Chambers, E., & Mitragotri, S. ( 2004 ). Prolonged circulation of large polymeric nanoparticles by non‐covalent adsorption on erythrocytes. Journal of Controlled Release, 100, 111 – 119. https://doi.org/10.1016/j.jconrel.2004.08.005 | |
dc.identifier.citedreference | Chambers, E., & Mitragotri, S. ( 2007 ). Long circulating nanoparticles via adhesion on red blood cells: Mechanism and extended circulation. Experimental Biology and Medicine, 232, 958 – 966. | |
dc.identifier.citedreference | Chang, T. Z., Deng, L., Wang, B.‐Z., & Champion, J. A. ( 2018 ). H7 Hemagglutinin nanoparticles retain immunogenicity after >3 months of 25 degrees C storage. PLoS One, 13, e0202300. https://doi.org/10.1371/journal.pone.0202300 | |
dc.identifier.citedreference | Chang, T. Z., Stadmiller, S. S., Staskevicius, E., & Champion, J. A. ( 2017 ). Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing. Biomaterials Science, 5, 223 – 233. https://doi.org/10.1039/c6bm00500d | |
dc.identifier.citedreference | Cheng, Z., Al, Z. A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. ( 2012 ). Multifunctional nanoparticles: Cost versus benefits of adding targeting and imaging capabilities. Science, 338, 903 – 910. https://doi.org/10.1126/science.1226338 | |
dc.identifier.citedreference | Choi, J., Kim, H., Jin, E., Jung, J., Park, J., Chung, H. K., … Jeong, S. Y. ( 2012 ). Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials, 33, 4195 – 4203. https://doi.org/10.1016/j.biomaterials.2012.02.022 | |
dc.identifier.citedreference | Corsten, M. F., & Shah, K. ( 2008 ). Therapeutic stem‐cells for cancer treatment: Hopes and hurdles in tactical warfare. The Lancet Oncology, 9, 376 – 384. https://doi.org/10.1016/S1470-2045(08)70099-8 | |
dc.identifier.citedreference | Deng, L., Mohan, T., Chang, T. Z., Gonzalez, G. X., Wang, Y., Kwon, Y. M., & Kang, S. M. ( 2018 ). Double‐layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nature Communications, 9, 359. https://doi.org/10.1038/s41467-017-02725-4 | |
dc.identifier.citedreference | Deng, Z. J., Morton, S. W., Ben‐Akiva, E., Dreaden, E. C., Shopsowitz, K. E., & Hammond, P. T. ( 2013 ). Layer‐by‐layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple‐negative breast cancer treatment. ACS Nano, 7, 9571 – 9584. https://doi.org/10.1021/nn4047925 | |
dc.identifier.citedreference | Desai, N. ( 2007 ). Nab technology: A drug delivery platform utilising endothelial gp60 receptor‐based transport and tumour‐derived SPARC for targeting. Drug Delivery Report, 16, 37 – 41. | |
dc.identifier.citedreference | Desai, N. P. ( 2014 ). Nanoparticle compositions of albumin and paclitaxel. U.S. Patent No. 13/794,705. Washington, DC: U.S. Patent and Trademark Office. | |
dc.identifier.citedreference | Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. ( 2009 ). Monocyte chemoattractant protein‐1 (MCP‐1): An overview. Journal of Interferon and Cytokine Research, 29, 313 – 326. https://doi.org/10.1089/jir.2008.0027 | |
dc.identifier.citedreference | Devaraj, N. K., Keliher, E. J., Thurber, G. M., & Nahrendorf, M. ( 2009 ). 18F Labeled nanoparticles for in vivo PET‐CT imaging. Bioconjugate Chemistry, 20, 397 – 401. https://doi.org/10.1021/bc8004649.18 | |
dc.identifier.citedreference | Ding, S., O’Banion, C. P., Welfare, J. G., & Lawrence, D. S. ( 2018 ). Cellular cyborgs: On the precipice of a drug delivery revolution. Cell Chemical Biology, 25, 648 – 658. https://doi.org/10.1016/j.chembiol.2018.03.003 | |
dc.identifier.citedreference | Doshi, N., Swiston, A. J., Gilbert, J. B., Alcaraz, M. L., Cohen, R. E., Rubner, M. F., & Mitragotri, S. ( 2011 ). Cell‐based drug delivery devices using phagocytosis‐resistant backpacks. Advanced Materials, 23, H105 – H109. https://doi.org/10.1002/adma.201004074 | |
dc.identifier.citedreference | Dreis, S., Rothweiler, F., Michaelis, M., Cinatl, J., Kreuter, J., & Langer, K. ( 2007 ). Preparation, characterisation and maintenance of drug efficacy of doxorubicin‐loaded human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics, 341, 207 – 214. https://doi.org/10.1016/j.ijpharm.2007.03.036 | |
dc.identifier.citedreference | Duarte, A. R., Ünal, B., Mano, J. F., Reis, R. L., & Jensen, K. F. ( 2014 ). Microfluidic production of perfluorocarbon‐alginate core‐shell microparticles for ultrasound therapeutic applications. Langmuir, 30, 12391 – 12399. https://doi.org/10.1021/la502822v | |
dc.identifier.citedreference | Ecker, D. M., Jones, S. D., & Levine, H. L. ( 2015 ). The therapeutic monoclonal antibody market. MAbs, 7, 9 – 14. https://doi.org/10.4161/19420862.2015.989042 | |
dc.identifier.citedreference | Estrada, L. H., Chu, S., & Champion, J. A. ( 2014 ). Protein nanoparticles for intracellular delivery of therapeutic enzymes. Journal of Pharmaceutical Sciences, 103, 1863 – 1871. https://doi.org/10.1002/jps.23974 | |
dc.identifier.citedreference | Evans, M. A., Huang, P. J., Iwamoto, Y., Ibsen, K. N., Chan, E. M., Hitomi, Y., … Mitragotri, S. ( 2018 ). Macrophage‐mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control. Chemical Science, 9, 3729 – 3741. https://doi.org/10.1039/c8sc00015h | |
dc.identifier.citedreference | Fathi, M., Donsi, F., & McClements, D. J. ( 2018 ). Protein‐based delivery Systems for the nanoencapsulation of food ingredients. Comprehensive Reviews in Food Science and Food Safety, 17, 920 – 936. https://doi.org/10.1111/1541-4337.12360 | |
dc.identifier.citedreference | Fiers, W., De Filette, M., El Bakkouri, K., Schepens, B., Roose, K., Schotsaert, M., … Saelens, X. ( 2009 ). M2e‐based universal influenza A vaccine. Vaccine, 27, 6280 – 6283. https://doi.org/10.1016/J.VACCINE.2009.07.007 | |
dc.identifier.citedreference | Fliervoet, L. A. L., & Mastrobattista, E. ( 2016 ). Drug delivery with living cells. Advanced Drug Delivery Reviews, 106, 63 – 72. https://doi.org/10.1016/j.addr.2016.04.021 | |
dc.identifier.citedreference | Garay, R. P., El‐Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. ( 2012 ). Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG‐conjugated agents. Expert Opinion on Drug Delivery, 9, 1319 – 1323. https://doi.org/10.1517/17425247.2012.720969 | |
dc.identifier.citedreference | Geiger, B. C., Wang, S., Padera, R. F., Grodzinsky, A. J., & Hammond, P. T. ( 2018 ). Cartilage‐penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis. Science Translational Medicine, 10, 1 – 12. https://doi.org/10.1126/scitranslmed.aat8800 | |
dc.identifier.citedreference | Gordon, S., & Taylor, P. R. ( 2005 ). Monocyte and macrophage heterogeneity. Nature Reviews. Immunology, 5, 953 – 964. https://doi.org/10.1038/nri1733 | |
dc.identifier.citedreference | Grivennikov, S. I., Greten, F. R., & Karin, M. ( 2010 ). Immunity, inflammation, and cancer. Cell, 140, 883 – 899. https://doi.org/10.1016/j.cell.2010.01.025 | |
dc.identifier.citedreference | Gröschel, A. H., Walther, A., Löbling, T. I., Schacher, F. H., Schmalz, H., & Müller, A. H. E. ( 2013 ). Guided hierarchical co‐assembly of soft patchy nanoparticles. Nature, 503, 247 – 251. https://doi.org/10.1038/nature12610 | |
dc.identifier.citedreference | Guo, Y., Yuan, W., Yu, B., Kuai, R., Hu, W., Morin, E. E., … Chen, Y. E. ( 2018 ). Synthetic high‐density lipoprotein‐mediated targeted delivery of liver X receptors agonist promotes atherosclerosis regression. EBioMedicine, 28, 225 – 233. https://doi.org/10.1016/j.ebiom.2017.12.021 | |
dc.identifier.citedreference | Hawkins, M. J., Soon‐Shiong, P., & Desai, N. ( 2008 ). Protein nanoparticles as drug carriers in clinical medicine. Advanced Drug Delivery Reviews, 60, 876 – 885. https://doi.org/10.1016/j.addr.2007.08.044 | |
dc.identifier.citedreference | Herrera Estrada, L. P., & Champion, J. A. ( 2015 ). Protein nanoparticles for therapeutic protein delivery. Biomaterials Science, 3, 787 – 799. https://doi.org/10.1039/C5BM00052A | |
dc.identifier.citedreference | Hong, L., Jiang, S., & Granick, S. ( 2006 ). Simple method to produce Janus colloidal particles in large quantity. Langmuir, 22, 9495 – 9499. https://doi.org/10.1021/la062716z | |
dc.identifier.citedreference | Huang, B., Abraham, W. D., Zheng, Y., Bustamante López, S. C., Luo, S. S., & Irvine, D. J. ( 2015 ). Active targeting of chemotherapy to disseminated tumors using nanoparticle‐carrying T cells. Science Translational Medicine, 7, 291ra94. https://doi.org/10.1126/scitranslmed.aaa5447 | |
dc.identifier.citedreference | Huang, X., Zhang, F., Wang, H., Niu, G., Choi, K. Y., Swierczewska, M., … Choi, H. S. ( 2013 ). Mesenchymal stem cell‐based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. Biomaterials, 34, 1772 – 1778. https://doi.org/10.1016/j.biomaterials.2012.11.032 | |
dc.identifier.citedreference | Hwang, S., & Lahann, J. ( 2012 ). Differentially degradable Janus particles for controlled release applications. Macromolecular Rapid Communications, 33, 1178 – 1183. https://doi.org/10.1002/marc.201200054 | |
dc.identifier.citedreference | Hwang, S., Roh, K.‐H., Lim, D. W., Wang, G., Uher, C., & Lahann, J. ( 2010 ). Anisotropic hybrid particles based on electrohydrodynamic co‐jetting of nanoparticle suspensions. Physical Chemistry Chemical Physics, 12, 11894 – 11899. https://doi.org/10.1039/c0cp00264j | |
dc.identifier.citedreference | Ingato, D., Uk, J., Jun, S., & Jik, Y. ( 2016 ). Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery. Journal of Controlled Release, 241, 174 – 185. https://doi.org/10.1016/j.jconrel.2016.09.016 | |
dc.identifier.citedreference | Jang, S. G., Choi, D. G., Heo, C. J., Lee, S. Y., & Yang, S. M. ( 2008 ). Nanoscopic ordered voids and metal caps by controlled trapping of colloidal particles at polymeric film surfaces. Advanced Materials, 20, 4862 – 4867. https://doi.org/10.1002/adma.200702851 | |
dc.identifier.citedreference | Jiang, P., Yu, C., Yen, C., & Woo, C. W. ( 2015 ). Irradiation enhances the ability of monocytes as nanoparticle carrier for cancer therapy. PLoS One, 10, 1 – 15. https://doi.org/10.1371/journal.pone.0139043 | |
dc.identifier.citedreference | Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., Hughes, S. H., & Chatterjee, D. K. ( 2011 ). Protein delivery using engineered virus‐like particles. Proceedings of the National Academy of Sciences, 108, 16998 – 17003. https://doi.org/10.2139/ssrn.2955110 | |
dc.identifier.citedreference | Kawakami, N., Kondo, H., Matsuzawa, Y., Hayasaka, K., Nasu, E., Sasahara, K., … Miyamoto, K. ( 2018 ). Design of hollow protein nanoparticles with modifiable interior and exterior surfaces. Angewandte Chemie, 57, 12400 – 12404. https://doi.org/10.1002/anie.201805565 | |
dc.identifier.citedreference | Kinoshita, R., Ishima, Y., Chuang, V. T., Nakamura, H., Fang, J., Watanabe, H., … Maruyama, T. ( 2017 ). Improved anticancer effects of albumin‐bound paclitaxel nanoparticle via augmentation of EPR effect and albumin‐protein interactions using S‐nitrosated human serum albumin dimer. Biomaterials, 140, 162 – 169. https://doi.org/10.1016/j.biomaterials.2017.06.021 | |
dc.identifier.citedreference | Klyachko, N. L., Polak, R., Haney, M. J., Zhao, Y., Gomes Neto, R. J., Hill, M. C., … Batrakova, E. V. ( 2017 ). Macrophages with cellular backpacks for targeted drug delivery to the brain. Biomaterials, 140, 79 – 87. https://doi.org/10.1016/j.biomaterials.2017.06.017 | |
dc.identifier.citedreference | Kuai, R., Subramanian, C., White, P. T., Timmermann, B. N., Moon, J. J., Cohen, M. S., & Schwendeman, A. ( 2017 ). Synthetic high‐density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma. International Journal of Nanomedicine, 12, 6581 – 6594. https://doi.org/10.2147/IJN.S140591 | |
dc.identifier.citedreference | Langer, K., Anhorn, M. G., Steinhauser, I., Dreis, S., Celebi, D., Schrickel, N., … Vogel, V. ( 2008 ). Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation. International Journal of Pharmaceutics, 347, 109 – 117. https://doi.org/10.1016/j.ijpharm.2007.06.028 | |
dc.identifier.citedreference | Lewis, C., & Murdoch, C. ( 2005 ). Macrophage responses to hypoxia. The American Journal of Pathology, 167, 627 – 635. https://doi.org/10.1016/S0002-9440(10)62038-X | |
dc.identifier.citedreference | Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., … Ji, S. ( 2011 ). Silica Nanorattle‐doxorubicin‐anchored mesenchymal stem cells for tumor‐tropic therapy. ACS Nano, 5, 7462 – 7470. https://doi.org/10.1021/nn202399w | |
dc.identifier.citedreference | Liang, B. Y., Jordahl, J. H., Ding, H., Deng, X., & Lahann, J. ( 2015 ). Uniform coating of microparticles using CVD polymerization. Chemical Vapor Deposition, 21, 288 – 293. https://doi.org/10.1002/cvde.201507197 | |
dc.identifier.citedreference | Liu, Y., Chen, Z., Liu, C., Yu, D., Lu, Z., & Zhang, N. ( 2011 ). Gadolinium‐loaded polymeric nanoparticles modified with anti‐VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Biomaterials, 32, 5167 – 5176. https://doi.org/10.1016/j.biomaterials.2011.03.077 | |
dc.identifier.citedreference | Liu, Y., Huang, B., Zhu, J., Feng, K., Yuan, Y., & Liu, C. ( 2018 ). Dual‐generation dendritic mesoporous silica nanoparticles for co‐delivery and kinetically sequential drug release. RSC Advances, 8, 40598 – 40610. https://doi.org/10.1039/c8ra07849a | |
dc.identifier.citedreference | Lopez, V., Rocio Villegas, M., Rodriguez, V., Villaverde, G., Lozano, D., Baeza, A., & Vallet‐Regí, M. ( 2017 ). Janus mesoporous silica nanoparticles for dual targeting of tumor cells and mitochondria. Applied Materials & Interfaces, 9, 26697 – 26706. https://doi.org/10.1021/acsami.7b06906 | |
dc.identifier.citedreference | Madsen, S. J., Christie, C., Hong, S. J., Trinidad, A., Peng, Q., Uzal, F. A., & Hirschberg, H. ( 2015 ). Nanoparticle‐loaded macrophage‐mediated photothermal therapy: Potential for glioma treatment. Lasers in Medical Science, 30, 1357 – 1365. https://doi.org/10.1007/s10103-015-1742-5 | |
dc.identifier.citedreference | Mimeault, M., Hauke, R., & Batra, S. K. ( 2007 ). Stem cells: A revolution in therapeutics—Recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clinical Pharmacology and Therapeutics, 82, 252 – 264. https://doi.org/10.1038/sj.clpt.6100301 | |
dc.identifier.citedreference | Misra, A. C., Bhaskar, S., Clay, N., & Lahann, J. ( 2012 ). Multicompartmental particles for combined imaging and siRNA delivery. Advanced Materials, 24, 3850 – 3856. https://doi.org/10.1002/adma.201200372 | |
dc.identifier.citedreference | Molino, N. M., & Wang, S. W. ( 2014 ). Caged protein nanoparticles for drug delivery. Current Opinion in Biotechnology, 28, 75 – 82. https://doi.org/10.1016/j.copbio.2013.12.007 | |
dc.identifier.citedreference | Mooney, R., Roma, L., Zhao, D., Van Haute, D., Garcia, E., Kim, S. U., … Berlin, J. M. ( 2014 ). Neural stem cell‐mediated intratumoral delivery of gold nanorods improves photothermal therapy. ACS Nano, 8, 12450 – 12460. https://doi.org/10.1021/nn505147w | |
dc.identifier.citedreference | Mooney, R., Weng, Y., Garcia, E., Bhojane, S., Smith‐Powell, L., Kim, S. U., … Berlin, J. M. ( 2014 ). Conjugation of pH‐responsive nanoparticles to neural stem cells improves intratumoral therapy. Journal of Controlled Release, 191, 82 – 89. https://doi.org/10.1016/j.jconrel.2014.06.015 | |
dc.identifier.citedreference | Moore, T. L., Hauser, D., Gruber, T., Rothen‐Rutishauser, B., Lattuada, M., Petri‐Fink, A., & Lyck, R. ( 2017 ). Cellular shuttles: Monocytes/macrophages exhibit transendothelial transport of nanoparticles under physiological flow. ACS Applied Materials & Interfaces, 9, 18501 – 18511. https://doi.org/10.1021/acsami.7b03479 | |
dc.identifier.citedreference | Morton, S. W., Lee, M. J., Deng, Z. J., Dreaden, E. C., Siouve, E., Shopsowitz, K. E., … Hammond, P. T. ( 2014 ). A nanoparticle‐based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways. Science Signaling, 7, ra44. https://doi.org/10.1126/scisignal.2005261 | |
dc.identifier.citedreference | Murdoch, C., Giannoudis, A., & Lewis, C. E. ( 2004 ). Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood, 104, 2224 – 2234. https://doi.org/10.1182/blood-2004-03-1109 | |
dc.identifier.citedreference | Muzykantov, V. R. ( 2010 ). Drug delivery by red blood cells: Vascular carriers designed by mother nature. Expert Opinion on Drug Delivery, 7, 403 – 427. https://doi.org/10.1517/17425241003610633 | |
dc.identifier.citedreference | Nahire, R., Haldar, M. K., Paul, S., Mergoum, A., Ambre, A. H., Katti, K. S., … Mallik, S. ( 2013 ). Polymer coated echogenic lipid nanoparticles with dual release triggers. Biomacromolecules, 14, 841 – 853. https://doi.org/10.1021/bm301894z.Polymer | |
dc.identifier.citedreference | Nie, Z., Li, W., Seo, M., Xu, S., & Kumacheva, E. ( 2006 ). Janus and ternary particles generated by microfluidic synthesis: Design, synthesis, and self‐assembly. Journal of the American Chemical Society, 128, 9408 – 9412. https://doi.org/10.1021/ja060882n | |
dc.identifier.citedreference | Nikravan, G., Haddadi‐Asl, V., & Salami‐kalajahi, M. ( 2018 ). Synthesis of dual temperature—And pH‐responsive yolk‐shell nanoparticles by conventional etching and new deswelling approaches: DOX release behavior. Colloids and Surfaces B: Biointerfaces, 165, 1 – 8. https://doi.org/10.1016/j.colsurfb.2018.02.010 | |
dc.identifier.citedreference | Nourshargh, S., & Alon, R. ( 2014 ). Leukocyte migration into inflamed tissues. Immunity, 41, 694 – 707. https://doi.org/10.1016/j.immuni.2014.10.008 | |
dc.identifier.citedreference | Palanikumar, L., Jeena, M. T., Kim, K., Oh, J. Y., Kim, C., Park, M. H., & Ryu, J. H. ( 2017 ). Spatiotemporally and sequentially‐controlled drug release from polymer gatekeeper—Hollow silica nanoparticles. Scientific Reports, 7, 1 – 11. https://doi.org/10.1038/srep46540 | |
dc.identifier.citedreference | Pan, D., Vargas‐Morales, O., Zern, B., Anselmo, A. C., Gupta, V., Zakrewsky, M., … Muzykantov, V. ( 2016 ). The effect of polymeric nanoparticles on biocompatibility of carrier red blood cells. PLoS One, 11, 1 – 17. https://doi.org/10.1371/journal.pone.0152074 | |
dc.identifier.citedreference | Pan, D. C., Myerson, J. W., Brenner, J. S., Patel, P. N., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. ( 2018 ). Nanoparticle properties modulate their attachment and effect on carrier red blood cells. Scientific Reports, 8, 1 – 12. https://doi.org/10.1038/s41598-018-19897-8 | |
dc.identifier.citedreference | Pang, L., Zhang, C., Qin, J., Han, L., Li, R., Hong, C., … Wang, J. ( 2017 ). A novel strategy to achieve effective drug delivery: Exploit cells as carrier combined with nanoparticles. Drug Delivery, 24, 83 – 91. https://doi.org/10.1080/10717544.2016.1230903 | |
dc.identifier.citedreference | Paunov, B. V. N., & Cayre, O. J. ( 2004 ). Supraparticles and “Janus” particles fabricated by replication of particle monolayers at liquid surfaces using a gel trapping technique. Advanced Materials, 16, 788 – 791. https://doi.org/10.1002/adma.200306476 | |
dc.identifier.citedreference | Pawar, A. B., & Kretzschmar, I. ( 2009 ). Multifunctional patchy particles by glancing angle deposition. Langmuir, 25, 9057 – 9063. https://doi.org/10.1021/la900809b | |
dc.identifier.citedreference | Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. ( 2007 ). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2, 751 – 760. https://doi.org/10.1038/nnano.2007.387 | |
dc.identifier.citedreference | Petit, L., Manaud, J. P., Mingotaud, C., Ravaine, S., & Duguet, E. ( 2001 ). Sub‐micrometer silica spheres dissymmetrically decorated with gold nanoclusters. Materials Letters, 51, 478 – 484. https://doi.org/10.1016/S0167-577X(01)00338-X | |
dc.identifier.citedreference | Rahmani, S., Ross, A. M., Park, T. H., Durmaz, H., Dishman, A. F., Prieskorn, D. M., … Lahann, J. ( 2016 ). Dual release carriers for Cochlear delivery. Advanced Healthcare Materials, 5, 94 – 100. https://doi.org/10.1002/adhm.201500141 | |
dc.identifier.citedreference | Rahmani, S., Saha, S., Durmaz, H., Donini, A., Misra, A. C., Yoon, J., & Lahann, J. ( 2014 ). Chemically orthogonal three‐patch microparticles. Angewandte Chemie, 53, 2332 – 2338. https://doi.org/10.1002/anie.201310727 | |
dc.identifier.citedreference | Rahmani, S., Villa, C. H., Dishman, A. F., Grabowski, M. E., Pan, D. C., Durmaz, H., … Lahann, J. ( 2015 ). Long‐circulating Janus nanoparticles made by electrohydrodynamic co‐jetting for systemic drug delivery applications. Journal of Drug Targeting, 23, 750 – 758. https://doi.org/10.3109/1061186X.2015.1076428 | |
dc.identifier.citedreference | Reddy, T. L., Rao, K., Reddy, S. G., Reddy, B. V. S., Yadav, J. S., Bhadra, U., & Bhadra, M. P. ( 2016 ). Simultaneous delivery of paclitaxel and Bcl‐2 siRNA via pH‐sensitive liposomal nanocarrier for the synergistic treatment of melanoma. Scientific Reports, 6, 1 – 12. https://doi.org/10.1038/srep35223 | |
dc.identifier.citedreference | Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. ( 2012 ). Adoptive immunotherapy for cancer: Harnessing the T cell response. Nature Reviews. Immunology, 12, 269 – 281. https://doi.org/10.1038/nri3191 | |
dc.identifier.citedreference | Reynolds, C. H., Annan, N., Beshah, K., Huber, J. H., Shaber, S. H., Lenkinski, R. E., & Wortman, J. A. ( 2000 ). Gadolinium‐loaded nanoparticles: New contrast agents for magnetic resonance imaging. Journal of the American Chemical Society, 122, 8940 – 8945. https://doi.org/10.1021/ja001426g | |
dc.identifier.citedreference | Roger, M., Clavreul, A., Venier‐Julienne, M. C., Passirani, C., Sindji, L., Schiller, P., … Menei, P. ( 2010 ). Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials, 31, 8393 – 8401. https://doi.org/10.1016/j.biomaterials.2010.07.048 | |
dc.identifier.citedreference | Roh, K., Martin, D. C., & Lahann, J. ( 2005 ). Biphasic Janus particles with nanoscale anisotropy. Nature Materials, 4, 759 – 763. https://doi.org/10.1038/nmat1486 | |
dc.identifier.citedreference | Roh, K. H., Martin, D. C., & Lahann, J. ( 2006 ). Triphasic nanocolloids. Journal of the American Chemical Society, 128, 6796 – 6797. https://doi.org/10.1021/ja060836n | |
dc.identifier.citedreference | Ruttala, H. B., & Ko, Y. T. ( 2015a ). Liposome encapsulated albumin‐paclitaxel nanoparticle for enhanced antitumor efficacy. Pharmaceutical Research, 32, 1002 – 1016. https://doi.org/10.1007/s11095-014-1512-2 | |
dc.identifier.citedreference | Ruttala, H. B., & Ko, Y. T. ( 2015b ). Liposomal co‐delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids and Surfaces B: Biointerfaces, 128, 419 – 426. https://doi.org/10.1016/J.COLSURFB.2015.02.040 | |
dc.identifier.citedreference | Ruttala, H. B., Ramasamy, T., Shin, B. S., Choi, H. G., Yong, C. S., & Kim, J. O. ( 2017 ). Layer‐by‐layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin‐bound paclitaxel. International Journal of Pharmaceutics, 519, 11 – 21. https://doi.org/10.1016/j.ijpharm.2017.01.011 | |
dc.identifier.citedreference | Sahdev, P., Ochyl, L. J., & Moon, J. J. ( 2014 ). Biomaterials for nanoparticle vaccine delivery systems. Pharmaceutical Research, 31, 2563 – 2582. https://doi.org/10.1007/s11095-014-1419-y | |
dc.identifier.citedreference | Shao, S., Shen, X., & Guo, M. ( 2018 ). Zinc‐loaded whey protein nanoparticles prepared by enzymatic cross‐linking and desolvation. International Journal of Food Science and Technology, 53, 2205 – 2211. https://doi.org/10.1111/ijfs.13809 | |
dc.identifier.citedreference | Shepard, K. B., Christie, D. A., Sosa, C. L., Arnold, C. B., & Priestley, R. D. ( 2015 ). Patchy Janus particles with tunable roughness and composition via vapor‐assisted deposition of macromolecules. Applied Physics Letters, 106, 093104. https://doi.org/10.1063/1.4913913 | |
dc.identifier.citedreference | Shimoda, A., Sawada, S., Kano, A., Maruyama, A., Winnik, M., & Akiyoshi, K. ( 2012 ). Dual crosslinked hydrogel nanoparticles by nanogel bottom‐up method for sustained‐release delivery. Colloids and Surfaces B: Biointerfaces, 99, 38 – 44. https://doi.org/10.1016/j.colsurfb.2011.09.025 | |
dc.identifier.citedreference | Singh, B., & Mitragotri, S. ( 2019 ). Harnessing cells to deliver nanoparticle drugs to treat cancer. Biotechnology Advances. https://doi.org/10.1016/j.biotechadv.2019.01.006 | |
dc.identifier.citedreference | Singla, A. K., Garg, A., & Aggarwal, D. ( 2002 ). Paclitaxel and its formulations. International Journal of Pharmaceutics, 235, 179 – 192. https://doi.org/10.1016/S0378-5173(01)00986-3 | |
dc.identifier.citedreference | Song, J., Wu, B., Zhou, Z., Zhu, G., Liu, Y., Yang, Z., … Duan, H. ( 2017 ). Double‐layered plasmonic–magnetic vesicles by self‐assembly of Janus amphiphilic gold–iron(II,III) oxide nanoparticles. Angewandte Chemie, 56, 8110 – 8114. https://doi.org/10.1002/anie.201702572 | |
dc.identifier.citedreference | Sparreboom, A., Scripture, C. D., Trieu, V., Williams, P., De, T., Yang, A., … Desai, N. ( 2005 ). Comparative preclinical and clinical pharmacokinetics of a cremophor‐free, nanoparticle albumin‐bound paclitaxel (ABI‐007) and paclitaxel formulated in cremophor (Taxol). Clinical Cancer Research, 11, 4136 – 4143. https://doi.org/10.1158/1078-0432.CCR-04-2291 | |
dc.identifier.citedreference | Stephan, M. T., Moon, J. J., Um, S. H., Bersthteyn, A., & Irvine, D. J. ( 2010 ). Therapeutic cell engineering with surface‐conjugated synthetic nanoparticles. Nature Medicine, 16, 1035 – 1041. https://doi.org/10.1038/nm.2198 | |
dc.identifier.citedreference | Strozyk, M. S., De Aberasturi, D. J., Gregory, J. V., Brust, M., Lahann, J., & Liz‐Marzán, L. M. ( 2017 ). Spatial analysis of metal—PLGA hybrid microstructures using 3D SERS imaging. Advanced Functional Materials, 1701626, 1 – 7. https://doi.org/10.1002/adfm.201701626 | |
dc.identifier.citedreference | Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., … Zhang, H. G. ( 2010 ). A novel nanoparticle drug delivery system: The anti‐inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Molecular Therapy, 18, 1606 – 1614. https://doi.org/10.1038/mt.2010.105 | |
dc.identifier.citedreference | Swiston, A. J., Cheng, C., Um, S. H., Irvine, D. J., Cohen, R. E., & Rubner, M. F. ( 2008 ). Surface functionalization of living cells with multilayer patches. Nano Letters, 8, 4446 – 4453. https://doi.org/10.1021/nl802404h | |
dc.identifier.citedreference | Swiston, A. J., Gilbert, J. B., Irvine, D. J., Cohen, R. E., & Rubner, M. F. ( 2010 ). Freely suspended cellular “backpacks” lead to cell aggregate self‐assembly. Biomacromolecules, 11, 1826 – 1832. https://doi.org/10.1021/bm100305h | |
dc.identifier.citedreference | Takahara, Y. K., Ikeda, S., Ishino, S., Tachi, K., Ikeue, K., Sakata, T., … Ohtani, B. ( 2005 ). Asymmetrically modified silica particles: A simple particulate surfactant for stabilization of oil droplets in water. Journal of the American Chemical Society, 127, 6271 – 6275. https://doi.org/10.1021/ja043581r | |
dc.identifier.citedreference | Tan, S., Wu, T., Zhang, D., & Zhang, Z. ( 2015 ). Cell or cell membrane‐based drug delivery systems. Theranostics, 5, 16 – 21. https://doi.org/10.7150/thno.11852 | |
dc.identifier.citedreference | Tan, Y. L., & Ho, H. K. ( 2018 ). Navigating albumin‐based nanoparticles through various drug delivery routes. Drug Discovery Today, 23, 1108 – 1114. https://doi.org/10.1016/j.drudis.2018.01.051 | |
dc.identifier.citedreference | Thao, L. Q., Lee, C., Kim, B., Lee, S., Kim, T. H., Kim, J. O., … Youn, Y. S. ( 2017 ). Doxorubicin and paclitaxel co‐bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma. Colloids and Surfaces B: Biointerfaces, 152, 183 – 191. https://doi.org/10.1016/j.colsurfb.2017.01.017 | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.